Venous and arterial thrombosis in patients with haematological malignancy during treatment with ibrutinib

Br J Haematol. 2019 Nov;187(3):399-402. doi: 10.1111/bjh.16209. Epub 2019 Sep 18.
No abstract available

Keywords: chronic lymphocytic leukaemia; ibrutinib; non-Hodgkin lymphoma; thrombosis (arterial); thrombosis (venous).

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Adult
  • Aged
  • Aged, 80 and over
  • Hematologic Neoplasms / complications
  • Hematologic Neoplasms / drug therapy*
  • Hemorrhage / etiology
  • Humans
  • Incidence
  • Middle Aged
  • Piperidines
  • Pyrazoles / adverse effects
  • Pyrazoles / therapeutic use*
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use*
  • Retrospective Studies
  • Risk Factors
  • Thrombosis / chemically induced*
  • Thrombosis / complications
  • Thrombosis / etiology
  • Thrombosis / therapy

Substances

  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine